Mortality study of 18 000 patients treated with omeprazole

DN Bateman; D Colin-Jones; S Hartz; Michael Langman; RF Logan; Jonathan Mant; MS Murphy; KR Paterson; R Rowsell; SG Thomas; M Vessey

doi:10.1136/gut.52.7.942

Mortality study of 18 000 patients treated with omeprazole

DN Bateman, D Colin-Jones, S Hartz, Michael Langman, RF Logan, Jonathan Mant, MS Murphy, KR Paterson, R Rowsell, SG Thomas, M Vessey

Research output: Contribution to journal › Article › peer-review

72 Citations (Scopus)

290 Downloads (Pure)

Abstract

Background: The long term safety of potent gastric acid suppressive therapy has yet to be established. Method: General practice record review at a median interval of 26 months followed by retrieval of details of all deaths within four years using the UK National Health Service Central Registers in 17 936 patients prescribed omeprazole in 1993–1995. Death rates were compared with general population rates. Results: Records of 17 489 patients (97.5%) were examined. A total of 12 703 patients received further scripts for antisecretory drugs, 8097 for omeprazole only (65.6%): 3097 patients have died. All cause mortality was higher in the first year (observed/expected (O/E) 1.44 (95% confidence intervals (CI) 1.34–1.55); p

Original language	English
Pages (from-to)	942-946
Number of pages	5
Journal	Gut
Volume	52
Issue number	7
DOIs	https://doi.org/10.1136/gut.52.7.942
Publication status	Published - 1 Jul 2003

Access to Document

10.1136/gut.52.7.942

GUT_2003_48.pdfFinal published version, 77.6 KB

http://gut.bmj.com/cgi/reprint/52/7/942

Cite this

@article{53b1a928642b42bb85c5885caaf60f22,

title = "Mortality study of 18 000 patients treated with omeprazole",

abstract = "Background: The long term safety of potent gastric acid suppressive therapy has yet to be established. Method: General practice record review at a median interval of 26 months followed by retrieval of details of all deaths within four years using the UK National Health Service Central Registers in 17 936 patients prescribed omeprazole in 1993–1995. Death rates were compared with general population rates. Results: Records of 17 489 patients (97.5%) were examined. A total of 12 703 patients received further scripts for antisecretory drugs, 8097 for omeprazole only (65.6%): 3097 patients have died. All cause mortality was higher in the first year (observed/expected (O/E) 1.44 (95% confidence intervals (CI) 1.34–1.55); p",

author = "DN Bateman and D Colin-Jones and S Hartz and Michael Langman and RF Logan and Jonathan Mant and MS Murphy and KR Paterson and R Rowsell and SG Thomas and M Vessey",

year = "2003",

month = jul,

day = "1",

doi = "10.1136/gut.52.7.942",

language = "English",

volume = "52",

pages = "942--946",

journal = "Gut",

issn = "1468-3288",

publisher = "BMJ Publishing Group",

number = "7",

}

TY - JOUR

T1 - Mortality study of 18 000 patients treated with omeprazole

AU - Bateman, DN

AU - Colin-Jones, D

AU - Hartz, S

AU - Langman, Michael

AU - Logan, RF

AU - Mant, Jonathan

AU - Murphy, MS

AU - Paterson, KR

AU - Rowsell, R

AU - Thomas, SG

AU - Vessey, M

PY - 2003/7/1

Y1 - 2003/7/1

N2 - Background: The long term safety of potent gastric acid suppressive therapy has yet to be established. Method: General practice record review at a median interval of 26 months followed by retrieval of details of all deaths within four years using the UK National Health Service Central Registers in 17 936 patients prescribed omeprazole in 1993–1995. Death rates were compared with general population rates. Results: Records of 17 489 patients (97.5%) were examined. A total of 12 703 patients received further scripts for antisecretory drugs, 8097 for omeprazole only (65.6%): 3097 patients have died. All cause mortality was higher in the first year (observed/expected (O/E) 1.44 (95% confidence intervals (CI) 1.34–1.55); p

AB - Background: The long term safety of potent gastric acid suppressive therapy has yet to be established. Method: General practice record review at a median interval of 26 months followed by retrieval of details of all deaths within four years using the UK National Health Service Central Registers in 17 936 patients prescribed omeprazole in 1993–1995. Death rates were compared with general population rates. Results: Records of 17 489 patients (97.5%) were examined. A total of 12 703 patients received further scripts for antisecretory drugs, 8097 for omeprazole only (65.6%): 3097 patients have died. All cause mortality was higher in the first year (observed/expected (O/E) 1.44 (95% confidence intervals (CI) 1.34–1.55); p

UR - http://www.scopus.com/inward/record.url?scp=0038798723&partnerID=8YFLogxK

U2 - 10.1136/gut.52.7.942

DO - 10.1136/gut.52.7.942

M3 - Article

C2 - 12801948

SN - 1468-3288

VL - 52

SP - 942

EP - 946

JO - Gut

JF - Gut

IS - 7

ER -

Mortality study of 18 000 patients treated with omeprazole

Abstract

Access to Document

Fingerprint

Cite this